Analgesics in Patients with Hepatic Impairment: Pharmacology and Clinical Implications

Author： Bosilkovska Marija  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.12, 2012-08, pp. : 1645-1669

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology of Morphine in Obese Patients: Clinical Implications

By >   Declèves Xavier   >   Basdevant Arnaud   Clement Karine   Bardin Christophe  

Clinical Pharmacokinetics, Vol. 48, Iss. 10, 2009-10 ,pp. : 635-651

Adis International

Access to resources Recommend Favorite

Central Effects of Non-Opioid Analgesics: Review of Actions and Their Clinical Implications

By Sandrini M.  

CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. : 337-345

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of the ketolide telithromycin after single and repeated doses in patients with hepatic impairment

By Cantalloube C.   Bhargava V.   Sultan E.   Vacheron F.   Batista I.   Montay G.  

International Journal of Antimicrobial Agents, Vol. 22, Iss. 2, 2003-08 ,pp. : 112-121

Elsevier

Access to resources Recommend Favorite

The dosing of anidulafungin does not require adjustment in patients with hepatic or renal impairment

By  

Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Antiretroviral Therapy: Pharmacokinetic Considerations in Patients with Renal or Hepatic Impairment

By McCabe Sarah M.   Qing   Slish Judianne C.   Catanzaro Linda M.   Sheth Neha   DiCenzo Robert   Morse Gene D.  

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 153-172

Adis International

Access to resources Recommend Favorite